Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
Hersh, 2011 | - | inadequate or absent control group |
Hersh Invest New Drugs 2011; 29:489-98 10.1007/s10637-009-9376-8 |
||
Wolchok, 2010 | - | inadequate or absent control group |
Wolchok Lancet Oncol. 2010; 11:155-64 10.1016/S1470-2045(09)70334-1 |